LXRX
Lexicon Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Lexicon Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Lexicon Pharmaceuticals, Inc.
1.42
−0.06 · −4.05%
post 1.42 0.00%
Fund move
Fund move
No thesis.
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Artal GroupArtal | $420.4M | 47.82% | +13.20% | |
| 2 | FMRFMR | $124.3M | 14.14% | +14.93% | |
| 3 | SirenSiren | $106.3M | 12.10% | 0.00% | |
| 4 | Sessa Capital IMSessa Capital IM | $45.5M | 5.18% | +5.85% | |
| 5 | BlackRockBlackRockindex-like | $41.6M | 4.74% | +422.20% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $23.8M | 2.70% | +4.01% | |
| 7 | Point72 Asset ManagementPoint72 | $19.8M | 2.25% | +5.59% | |
| 8 | Geode Capital ManagementGeodeindex-like | $15.0M | 1.71% | +97.04% | |
| 9 | State StreetState Streetindex-like | $11.8M | 1.34% | +410.12% | |
| 10 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $5.7M | 0.64% | +331.35% | |
| 11 | Citadel AdvisorsCitadel | $4.8M | 0.54% | +17.84% | |
| 12 | Northern TrustNorthern Trustindex-like | $4.7M | 0.54% | +297.97% | |
| 13 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.7M | 0.53% | +49.22% | |
| 14 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $3.9M | 0.45% | new | |
| 15 | Susquehanna International GroupSusquehanna International | $3.3M | 0.38% | −50.00% | |
| 16 | Ishara InvestmentsIshara | $3.1M | 0.35% | +40.91% | |
| 17 | Millennium ManagementMillennium | $2.7M | 0.31% | −77.06% | |
| 18 | Renaissance TechnologiesRenaissance Technologies | $2.7M | 0.31% | −29.58% | |
| 19 | Mackenzie FinancialMackenzie Financial | $2.3M | 0.26% | +24.68% | |
| 20 | ADAR1 Capital ManagementADAR1 | $1.8M | 0.20% | 0.00% | |
| 21 | Acadian Asset ManagementAcadian | $1.7M | 0.19% | +56.44% | |
| 22 | UBS GroupUBS | $1.6M | 0.19% | −72.43% | |
| 23 | Two Sigma InvestmentsTwo Sigma | $1.5M | 0.18% | −46.36% | |
| 24 | NuveenNuveenindex-like | $1.4M | 0.16% | new | |
| 25 | Jane Street GroupJane Street | $1.4M | 0.16% | −82.00% |
149 managers report $879.1M of Lexicon Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 5 of them hold 80% of it; Artal is largest at 47.82%.
Expected move
Inputsspot 1.42exp Nov 20ATM strike 1.5ATM straddle 0.35IV 124%